Label Changes for:

Pristiq (desvenlafaxine) Extended-Release Tablets

February 2013

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) 

February 2013

 

ADVERSE REACTIONS

Clinical Studies Experience
Patient exposure
Advertisement
Close

Recommended

(web2)